RP 2019 now rising PSA and PSMA with ... - Prostate Cancer N...

Prostate Cancer Network

4,935 members3,071 posts

RP 2019 now rising PSA and PSMA with most likely metastatic lymph node- any comments or advice on treatment plan?

WickedNeptune profile image
20 Replies

Hey! I am a rookie here! So much respect for this site and the great guys and gals that contribute. Any feedback would be appreciated!

I chose RP to deal with my PC

RP February 2019- Gleason 3 + 4 = 7 Tertiary pattern 5

Extraprostatic extension of tumor.

After RP of 2/07/2019-

PSA- Undetectable until 2021- all PSAs below in 2021

March 21- .07

July 21- .11

September 21- .15

December 7- .24

December 15- .17 (different lab)

PSMA November 13, 2021- lymph node concerning on right side of pelvis

IMPRESSION:

Subcentimeter tracer avid node in the right iliac chain most likely representing metastatic lymph node. There is no other tracer avid distant metastases.

I met with local urologist- recommend radiation to prostate area with no ADT. But he did not have the benefit of PSMA.

I met with Dr. Deville at Johns Hopkins and he suggested a 6 month course of Orgovyx and 37 or so radiation treatments. I had been of the mind that there was an increased benefit from the hormone treatment along with the radiation, which he voiced as well. A second opinion at Duke with Dr. Lee agreed with the plan. So I started on the Orgovyx on Christmas eve- so more than a month in. Start radiation at JH February 7th.

As far as the hormones, here are my numbers before ADT on

December 15 - PSA 0.17, Test 780

Decipher score is 41.

Below is pathology from RP-

Prostate (Radical Prostatectomy, TS-19-05686, 2/4/2019):

HISTOLOGIC TYPE

Adenocarcinoma (conventional, NOS)

GLEASON SCORE, DOMINANT NODULE

3+4=7

Grade Group 2

40% Pattern 4 (tertiary pattern 5)

TUMOR EXTENT

Tumor dimension (max): 24.0 mm

LOCATION, DOMINANT NODULE

Left/Right

Lateral/Posterolateral/Posterior

Mid

LOCAL EXTENT

Extraprostatic extension

Right Posterolateral/Posterior Base, Non-Focal

MARGINS

Negative

LYMPHATIC (SMALL VESSEL) INVASION

Absent

EXTENT OF INVASION (8th Edition AJCC)

PRIMARY TUMOR

pT3a: Extraprostatic extension or microscopic bladder neck invasion

SUMMARY MARGINS

Negative

ADDITIONAL FINDINGS, UNINVOLVED PROSTATE

Prostatic intraductal adenocarcinoma

NOTE

The pattern 4 has in areas a cribriform morphology

Written by
WickedNeptune profile image
WickedNeptune
To view profiles and participate in discussions please or .
Read more about...
20 Replies
Tall_Allen profile image
Tall_Allen

When there are known cancerous pelvic lymph nodes, at least 2 years of adjuvant ADT is required, possibly with advanced hormone therapy. Consider this randomized clinical trial - it seems perfect for you:

clinicaltrials.gov/ct2/show...

conbio profile image
conbio in reply to Tall_Allen

Hey TA - thanks for the usual solid advice. A side question - is there any consolidated site to look at current and applicable trials? Thanks

Tall_Allen profile image
Tall_Allen in reply to conbio

clinicaltrials.gov

WickedNeptune profile image
WickedNeptune in reply to Tall_Allen

Thank you for advice. I searched this site and the only study that I could find regarding the length and type of ADT is below which does lend credence to the advantage of the use of a 24 months of ADT with radiation in the salvage setting over radiation alone. Are there studies that show that longer than 6 months ADT is advantageous? Your time and information is GREATLY appreciated!

businesswire.com/news/home/...

Also, should I consider any radiation therapy besides IMRT. I got the idea from one of London441's posts that you made a alternate suggestion.

I am new here and hope that my questions are not inartful!

Tall_Allen profile image
Tall_Allen in reply to WickedNeptune

The standard-of-care when there are pelvic lymph node metastases is 2-3 years. I have no idea where you are getting 6 months from. The best info we have comes from the following study:

prostatecancer.news/2017/12...

The new clinical trial that I showed you will establish a new standard of care. The only open question is whether extra hormone therapy helps.

That link has nothing to do with your situation - you are not distantly metastatic (stage M1), your cancer is only in your pelvic lymph nodes (stage N1).

I don't know what other kind of radiation you mean - hypofractionation? protons? Yes, they are possible too. Hypofractionation is a good idea during the pandemic.

WickedNeptune profile image
WickedNeptune in reply to Tall_Allen

Thank you again. The 6 months came from DeVille at johns hopkins and Lee at Duke. I will address this will DeVille.

Tall_Allen profile image
Tall_Allen in reply to WickedNeptune

I don't know either of them. JH is not known for radiation oncology. I only know of Bridget Koontz at Duke. I can also recommend Sean Collins at Georgetown.

WickedNeptune profile image
WickedNeptune in reply to Tall_Allen

Allen- had a phone consult with Dr. Collins and he agreed with length of ADT.

He did say that I could consider radiation to the lymph nodes only for 5 treatments which would drastically reduce any risks of complications. But he said that radiation to the whole area would give me a higher percentage chance of a better outcome longer term. So I am going to press on with the plan for 35 treatments.

Tall_Allen profile image
Tall_Allen in reply to WickedNeptune

Did he say why the shortened course of ADT was ok with him? Whole area - definitely!

WickedNeptune profile image
WickedNeptune in reply to Tall_Allen

All three DeVille/JH, Lee/Duke and Collins all said no evidence that longer is better in this context with my presentation.DeVille also drew a distinction with my case from the study that London441 was in.

Yes to whole area! I appreciate your input. Glad I discussed with all 3. Of course, the opinion could change during my six months ADT.

Tall_Allen profile image
Tall_Allen in reply to WickedNeptune

Look at the clinical trial I cited. All patients in your situation will be getting 2 years of adjuvant ADT. If they are randomized to Arm 2, they will also get apalutamide for 2 years. This is an NRG Oncology/NCI randomized clinical trial, which considered to be the best.

clinicaltrials.gov/ct2/show...

I think this is based on the finding in the Touijer study (discussed in article) that long-term adjuvant ADT is needed along with salvage radiation in men in whom positive LNs have been discovered.

prostatecancer.news/2017/12...

But as you say, you have time to decide that.

London441 profile image
London441

I had RP in 2019 also, at Johns Hopkins. Deville was my RO but only to administer the radiation, as part of my post op additional treatment clinical trial. My MO in charge of the trial is a Hopkins doc as well.

I’m surprised he would recommend only 6 months ADT for you. My pathology was similar, and I was on it for 18 months, which was shortened from 2 years. You had only RP in February’19?

WickedNeptune profile image
WickedNeptune in reply to London441

London- what ADT meds were you taking/administered? Who is the doc in charge of the trial?

Yes to only RP February 2019. Due to start radiation in 1 week.

And thanks!

London441 profile image
London441 in reply to WickedNeptune

I suppose I am one of those that ‘hit this aggressive early on’, as Dublin 1717 says.It wasn’t necessarily in my plan, but I was strongly advised to do it and followed that direction.

Lupron, plus Zytiga/prednisone. The Zytiga was for the first 3 months only. Concurrently with 4 cycles Taxotere chemo followed by 37 sessions of IMRT at 6 months. Lupron switched to Eligard (same drug, supply issue).

I finished with the treatments September’20.

I hope your salvage therapy works well for you! Glad you are taking Orgovyx, with its faster elimination from the body when stopped. The Lupron took its time leaving mine.

Neither the Orgovyx or PSMA were available to me when my trial commenced only

2 1/2 years ago.

Dr Ken Pienta is the MO.

dublin1717 profile image
dublin1717

Hi there wickedneptune, My husband had RP July 2020 and it all sounds pretty much like your case, he’s just had his first PSA rise so I’m following you buddy to see how you go. One thing we’ve learnt from this site is to hit this aggressive early on. I’m sure more of the absolute diamonds on this site will give you their opinion to help you with your decision making. Like you I’m so grateful to be here. Wishing you the best and with you now from here on in all the way. Please keep in touch ☘️

WickedNeptune profile image
WickedNeptune in reply to dublin1717

Dublin- would be happy to share my treatment! Love your attitude!

WickedNeptune profile image
WickedNeptune in reply to dublin1717

had the treatment - 6 months ADT with 35 radiation treatments- this spring. So far PSA undetectable. Testosterone was 190 recently- up from 0. Feeling great.

Some doctors are less enthusiastic about long courses of ADT than others.

WickedNeptune profile image
WickedNeptune in reply to

What did you decide? 2 or 3 years?

I didn’t have an avid node, just suspicious, so less. I’m curious what your doctor said about 6 months for an avid iliac node. There are a lot of reasons that could be behind that recommendation so I think you should ask him specifically and let us know.

Ultimately you will decide how long your course is, anyway.

You may also like...

surgical pathology - IDC

Status: All margins negative for invasive carcinoma REGIONAL LYMPH NODES Regional Lymph Node...

My Prostate Pathology Report

Positive Margin(s): Right anterior Gleason Pattern at Positive Margin(s): Pattern 3 LYMPH NODES...

Positive Margins -- Will I need additional treatment?

Extraprostatic Extension (EPE): Not identified Gleason Pattern at Margin(s) Involved by Carcinoma:...

PSA Ultrasensitive 0.015 six months after prostatectomy

in Area of Extraprostatic Extension (EPE): Not identified Gleason Pattern at Margin(s)...

Is radiation therapy warranted

prostatectomy in June 2019 at age 52. Final pathology report: Gleason 7 (3+4); Extraprostatic...